|





     
 


 


 


|

 
  

 
   
 
   

Ketorolac Toradol Nonsteroidal anti- - Inhibits prostaglandin Short term - Hypersensitivity - CNS: - Patients who have
inflammatory agents, synthesis, producing management of pain - Cross-sensitivity with 1) drowsiness asthma, aspirin-
nonopioid analagesics peripherally mediated (not to exceed 5 days other NSAIDs may 2) abnormal thinking induced allergy, and
analgesia total for all routes exist¨Pre- or 3) dizziness nasal polyps are at
- Also has antipyretic combined) perioperative use 4) euphoria increased risk for
and anti-inflammatory - Known alcohol 5) headache- developing
properties. intoleranceUse - RESP: hypersensitivity
- Therapeutic cautiously in: 1) asthma reactions. Assess for
effect:Decreased pain 1) History of GI 2) dyspnea rhinitis, asthma, and
bleeding - CV: urticaria.
2) Renal impair-ment 1) edema - Assess pain (note
(dosage reduction may 2) pallor type, location, and
be required) 3) vasodilation intensity) prior to and
3) Cardiovascular - GI: 1-2 hr following
disease 1) GI Bleeding administration.
2) abnormal taste - Ketorolac therapy
3) diarrhea should always be given
4) dry mouth initially by the IM or IV
5) dyspepsia route. Oral therapy
6) GI pain should be used only as
7) nausea a continuation of
- GU: parenteral therapy.
1) oliguria - Caution patient to
2) renal toxicity avoid concurrent use
3) urinary frequency of alcohol, aspirin,
- DERM: NSAIDs,
1) pruritis acetaminophen, or
2) purpura other OTC medications
3) sweating without consulting
4) urticaria health care
- HEMAT: professional.
1) prolonged bleeding - Advise patient to
time consult if rash, itching,
- LOCAL: visual disturbances,
1) injection site pain tinnitus, weight gain,
- NEURO: edema, black stools,
1) paresthesia persistent headche, or
- MISC: influenza-like
1) allergic reaction, syndromes
anaphylaxis (chills,fever,muscles
aches, pain) occur.
- Effectiveness of
therapy can be
demonstrated by
decrease in severity of
pain. Patients who do
not respond to one
NSAIDs may respond
to another.
 Adjunct to diet in Contraindicated CNS:Headache, Assess patient
Simvastati ý
 the treatment of
with allergy to for signs
elevated total asthenia,
n cholestrol and LDL simvastatin, sleep andsymptoms
cholesterol with fungal ofinfection
40mg/tab primary byproducts,
disturbances
ͻAssess for
hypercholesterole GI: Flatulence,
1 mia (types IIa and
pregnancy,
diarrhea,
anaohylaxis:
IIb) in those lactation. rash, urticaria,
tab OD at unresponsive to
abdominal chills, fever,
dietary restriction pain, dyspnea
hs of saturated fat cramps,
and cholesterol
(p.o.) and other constipation, ͻIdentify urine
nonpharmacologic nausea, output
measures dyspepsia, ͻAssess bowel
pattern daily
ͻ
To reduce the risk heartburn, Monitor for
of coronary bleeding
disease, mortality,
liver failure
and CV events, Respiratory:Sin
including stroke, usitis,
TIA, MI and
reduction in need pharyngitis
for bypass surgery Other:Rhabdo
and angionplasty myolysis,
in patients with
coronary heart acute renal
disease and failure,
hypercholesterole
mia
arthralgia,
myalgia
ͻ
Treatment of
patients with
isolated
hypertriglyceridem
ia

ͻ
Treatment of type
III
hyperlipoproteine
mi
ͻTreatment of
adolescents 10-17
yr with
heterozygous
familial
hypercholesterole
mia